Page 3

Drugmakers set to gain as taxpayers foot new opioid costs

By Liz Essley Whyte and Matthew Perrone

Key findings of investigation into harder-to-abuse opioids

Meet the 10 shadowy groups that snuck into your state races

By Kytja Weir, Chris Zubak-Skees and Ben Wieder

Left counters election losses with ballot measure victories

By Liz Essley Whyte

GOP dominates Democrats in governors’ races

By Michael J. Mishak and Ben Wieder

10 things to know about 2016's state elections

By Kytja Weir and Ben Wieder

The surprising way that governor candidates namedrop Trump, Clinton and Obama in TV ads

By Kytja Weir

Insurers give big to races determining their regulators

By Michael J. Mishak

National groups spar over South Dakota ballot measure

By Liz Essley Whyte

Tight governors' races loosen political purse strings

By Ben Wieder

Tracking TV ads in the 2016 state races

By Chris Zubak-Skees and Ben Wieder

Who's trying to influence 2016 state elections?

By Kytja Weir and Chris Zubak-Skees

Drinks, dinners, junkets and jobs: how the insurance industry courts state commissioners

By Michael J. Mishak

Pro-painkiller echo chamber shaped policy amid drug epidemic

By Matthew Perrone and Ben Wieder

Politics of pain: Drugmakers fought state opioid limits amid crisis

By Liz Essley Whyte, Geoff Mulvihill and Ben Wieder

Pharma lobbying held deep influence over opioid policies